Physicians are cautioned that the two obstacles to reforming post-marketing clinical trials are the FDA's reluctance to revisit past approvals and its inability to enforce pharmaceutical companies' commitment to conduct Phase IV trials.
Research is critical to the development of public policy as it relates to the need for expedited therapy for the partners of patients with a sexually transmitted disease.
A physician advocate who has taken public advocacy stances against the federal government while employed by the government talks about the conflicts that arise between medicine and politics.
A physician member of Congress gives a first-hand account of how she has balanced medicine and politics and how she views her responsibility to the patients of America.
A physician argues that every clinician should expand themselves beyond individual patient care and on some level adopt a public role within their community.